Nuvectis Pharma, Inc. (NVCT)
23.87
+0.31
(+1.32%)
USD |
NASDAQ |
Aug 24, 16:00
23.86
-0.01
(-0.04%)
After-Hours: 20:00
Nuvectis Pharma Total Assets (Quarterly) : 22.38M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.38M |
| March 31, 2026 | 25.40M |
| December 31, 2025 | 31.71M |
| September 30, 2025 | 35.59M |
| June 30, 2025 | 27.01M |
| March 31, 2025 | 30.15M |
| December 31, 2024 | 18.61M |
| September 30, 2024 | 17.31M |
| June 30, 2024 | 18.30M |
| March 31, 2024 | 19.71M |
| December 31, 2023 | 19.18M |
| Date | Value |
|---|---|
| September 30, 2023 | 22.26M |
| June 30, 2023 | 24.94M |
| March 31, 2023 | 16.21M |
| December 31, 2022 | 20.40M |
| September 30, 2022 | 24.87M |
| June 30, 2022 | 14.24M |
| March 31, 2022 | 17.62M |
| December 31, 2021 | 6.657M |
| September 30, 2021 | 6.809M |
| June 30, 2021 | 7.214M |
| March 31, 2021 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Decoy Therapeutics, Inc. | 9.001M |
| Unicycive Therapeutics, Inc. | 72.03M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.29M |
| Shareholders Equity (Quarterly) | 9.082M |
| Current Ratio | 1.683 |